# APADAZ

NDC: 70040-0145
Generic name: Benzhydrocodone and Acetaminophen
Labeler / Manufacturer: Zevra Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20180223

FDA application: NDA208653

## Active ingredients

- ACETAMINOPHEN: 325 mg/1
- BENZHYDROCODONE HYDROCHLORIDE: 4.08 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70040-0145"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70040-0145
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0590d4e5-7107-4015-a6a8-deac14265aa2